Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

3.2K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
3.2K
Transducer Mechanism: G Protein–Coupled Receptors01:30

Transducer Mechanism: G Protein–Coupled Receptors

8.2K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
8.2K
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

16.0K
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
16.0K
G-protein Coupled Receptors01:21

G-protein Coupled Receptors

134.5K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
134.5K
G-protein Coupled Receptors01:21

G-protein Coupled Receptors

7.1K
7.1K
Cell Signaling in Plants01:25

Cell Signaling in Plants

7.1K
Plant cells communicate to coordinate their cycle of growth, flowering and fruiting, and activities in roots, shoots, and leaves in response to the changing environmental conditions. Plant signaling is distinct from animal signaling. Plants primarily utilize enzyme-linked receptors, whereas the largest class of cell-surface receptors in animals are G-protein coupled receptors (GPCRs). Unlike animals, receptor tyrosine kinases are rare in plants. Instead, plants have a diverse class of...
7.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Extending the temporal window of arbovirus evolutionary analysis through the recovery of a century-old bandavirus.

Virus evolution·2026
Same author

A phase 1 clinical trial of a multi-antigen SARS-CoV DNA vaccine as a booster after dose three spike-based mRNA vaccinations.

Molecular therapy. Advances·2026
Same author

The RNA helicase eIF4A as a novel target in insect cells to combat arboviral infections.

PloS one·2026
Same author

PARANOiD: Pipeline for Automated Read ANalysis of iCLIP Data.

Bioinformatics (Oxford, England)·2025
Same author

JAK inhibitors remove innate immune barriers facilitating viral propagation.

NAR molecular medicine·2025
Same author

A Single Dose of Live-Attenuated Rift Valley Fever Virus Vector Expressing Peste Des Petits Ruminants Virus (PPRV) H or F Antigens Induces Immunity in Sheep.

Vaccines·2025
Same journal

The multifaceted role of acetamide derivative of chalcone: Anti-inflammatory action and impact on osteoclastogenesis, insights on NF-κB and MAPK pathway.

Cytokine·2026
Same journal

Icariin alleviates ovariectomy-induced osteoporosis by promoting M2 macrophage polarization and suppressing osteoclast activation.

Cytokine·2026
Same journal

Single-cell profiling of the immune landscape at the maternal-fetal interface in unexplained recurrent miscarriage.

Cytokine·2026
Same journal

EGFR as a context-dependent modulator of endothelial inflammation: A systematic review.

Cytokine·2026
Same journal

Harnessing the Power of IL-12: Revolutionizing Cancer Therapy with Combinatorial Strategies.

Cytokine·2026
Same journal

Corrigendum to "CCL17 and CCL19 are markers of disease progression in alveolar echinococcosis" [Cytokine 181 (2024) 156669].

Cytokine·2026
See all related articles

Related Experiment Video

Updated: Apr 7, 2026

Monitoring Activation of the Antiviral Pattern Recognition Receptors RIG-I And PKR By Limited Protease Digestion and Native PAGE
12:43

Monitoring Activation of the Antiviral Pattern Recognition Receptors RIG-I And PKR By Limited Protease Digestion and Native PAGE

Published on: July 29, 2014

12.8K

The catcher in the RIG-I.

Friedemann Weber1

  • 1Institute for Virology, FB10-Veterinary Medicine, Justus-Liebig University, D-35392 Giessen, Germany.

Cytokine
|July 15, 2015
PubMed
Summary
This summary is machine-generated.

Retinoic-acid inducible gene I (RIG-I) directly inhibits viral RNA replication early in infection. RIG-I also triggers a delayed immune response through interferon signaling.

Keywords:
Antiviral activityInterferon inductionPathogen recognition receptorRIG-I

More Related Videos

Optimizing the Genetic Incorporation of Chemical Probes into GPCRs for Photo-crosslinking Mapping and Bioorthogonal Chemistry in Live Mammalian Cells
14:02

Optimizing the Genetic Incorporation of Chemical Probes into GPCRs for Photo-crosslinking Mapping and Bioorthogonal Chemistry in Live Mammalian Cells

Published on: April 9, 2018

9.2K
A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
07:41

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators

Published on: February 20, 2018

9.6K

Related Experiment Videos

Last Updated: Apr 7, 2026

Monitoring Activation of the Antiviral Pattern Recognition Receptors RIG-I And PKR By Limited Protease Digestion and Native PAGE
12:43

Monitoring Activation of the Antiviral Pattern Recognition Receptors RIG-I And PKR By Limited Protease Digestion and Native PAGE

Published on: July 29, 2014

12.8K
Optimizing the Genetic Incorporation of Chemical Probes into GPCRs for Photo-crosslinking Mapping and Bioorthogonal Chemistry in Live Mammalian Cells
14:02

Optimizing the Genetic Incorporation of Chemical Probes into GPCRs for Photo-crosslinking Mapping and Bioorthogonal Chemistry in Live Mammalian Cells

Published on: April 9, 2018

9.2K
A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
07:41

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators

Published on: February 20, 2018

9.6K

Area of Science:

  • Immunology
  • Virology
  • Molecular Biology

Background:

  • Retinoic-acid inducible gene I (RIG-I) is a key pattern recognition receptor in innate immunity.
  • RIG-I functions as a cytoplasmic RNA helicase, recognizing virus-specific RNA structures.
  • RIG-I activation leads to signaling through the MAVS-IRF-3 pathway, inducing antiviral interferons.

Purpose of the Study:

  • To investigate the dual mechanisms of RIG-I in antiviral defense.
  • To explore RIG-I's direct inhibition of viral replication independent of downstream signaling.
  • To understand RIG-I's role in combating influenza A virus and hepatitis B virus.

Main Methods:

  • Analysis of RIG-I binding to viral RNA structures.
  • Assessment of RIG-I's impact on viral replication.
  • Investigation of RIG-I signaling pathways (MAVS-IRF-3 axis).

Main Results:

  • RIG-I directly binds to regulatory RNA structures of influenza A and hepatitis B viruses.
  • This binding inhibits viral replication independently of RIG-I's signaling function.
  • Activated RIG-I initiates a two-pronged antiviral strategy.

Conclusions:

  • RIG-I employs a dual mechanism for antiviral defense: early direct inhibition and delayed signaling-induced immunity.
  • RIG-I's direct RNA binding offers a novel therapeutic target for viral infections.
  • Understanding RIG-I's functions is crucial for developing new antiviral strategies.